Streetbeat News

Price Targets

MEIP

Brookline Capital has reiterated its Buy rating for MEI Pharma, maintaining an $80 price target.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 3:47 pm

STOK

Stoke Therapeutics shares are trading higher after Cantor Fitzgerald maintained an Overweight rating on the stock and raised its price target from $20 to $25.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 3:43 pm

IOVA

Iovance Biotherapeutics shares are trading higher after Baird maintained an Outperform rating on the stock and raised its price target from $20 to $23.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 3:41 pm

ESRT

Evercore ISI Group analyst Steve Sakwa upgrades Empire State Realty Trust (NYSE:ESRT) from In-Line to Outperform and raises the price target from $7 to $8.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 3:41 pm

MYGN

Goldman Sachs upgraded Myriad Genetics from Sell to Buy and raised its price target from $18 to $25, causing the stock to trade higher.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 3:41 pm

UPST

Compass Point analyst Giuliano Bologna maintains a Sell rating on Upstart Holdings (NASDAQ:UPST) and raises the price target from $6 to $8.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 3:36 pm

AVGO

A whale has taken a bearish stance on Broadcom (NASDAQ:AVGO), with 68% of detected unusual options trades being bearish. Whales have been targeting a price range of $310 to $740 for Broadcom over the last 3 months. B of A Securities maintains a Buy rating with an $800 price target.

Portfolio Pulse from Benzinga Insights

May 23, 2023 | 3:32 pm

QTRX

Goldman Sachs upgraded Quanterix stock from Neutral to Buy and raised its price target from $13 to $27, resulting in the stock trading higher.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 3:24 pm

BALY

Jefferies analyst David Katz maintains a Hold rating on Ballys (NYSE:BALY) and lowers the price target from $22 to $18.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 3:20 pm

AVGO

B of A Securities analyst Vivek Arya maintains a Buy rating on Broadcom (NASDAQ:AVGO) and raises the price target from $725 to $800.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2023 | 3:18 pm